Accounts Receivable, after Allowance for Credit Loss, Current of Ping An Biomedical Co., Ltd. from 30 Sep 2024 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD and CNY
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: Ping An Biomedical Co., Ltd. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 30 Sep 2024 to 30 Sep 2025.
Ping An Biomedical Co., Ltd. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2025 was $2,378,266.
Ping An Biomedical Co., Ltd. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in CNY history and change rate from 30 Sep 2024 to 30 Sep 2025.
Ping An Biomedical Co., Ltd. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2025 was ¥16,930,876, a 58% decline year-over-year.
Source SEC data: View on sec.gov

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (CNY)

Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Ping An Biomedical Co., Ltd. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$2,378,266			30 Sep 2025	20-F	30 Jan 2026	2025	FY
Q1 2025	$4,134,576			31 Mar 2025	6-K	29 Sep 2025	2025	Q2

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	¥16,930,876	-¥23,510,420	-58%	30 Sep 2025	20-F	30 Jan 2026	2025	FY
Q1 2025	¥30,003,375			31 Mar 2025	6-K	29 Sep 2025	2025	Q2
Q3 2024	¥40,441,296			30 Sep 2024	20-F	30 Jan 2026	2025	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.